A Study Comparing the Safety and Effectiveness of Cartilage Cell Injected Into the Lumbar Disc as Compared to a Placebo

NCT01771471 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

44

Enrollment

INDUSTRY

Sponsor class

Stopped Change in clinical strategy

Conditions

Degenerative Disc Disease

Interventions

BIOLOGICAL: NuQu
OTHER: Placebo

Sponsor

ISTO Technologies, Inc.